- Nachrichtendetail
-
01.04.2024 14:15:09 - dpa-AFX: *VERTEX ADVANCES INAXAPLIN INTO PHASE 3 PORTION OF PHASE 2/3 TRIAL FOR TREATMENT OF APOL1-MEDIATED KIDNEY DISEASE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
VERTEX PHARMAC. DL-,01 | 882807 | Xetra | 405,000 | 30.05.24 15:27:40 | -5,100 | -1,24% | 404,350 | 406,250 | 407,350 | 410,100 |
